According to the letter, the company lacked a testing protocol to ensure all devices met pre-determined design specifications and failed to validate the effect of manufacturing operations that incorporate metallic spikes into Trilogy devices.
As a result, the Puerto Rico facility has been temporarily closed as Zimmer works to implement the FDA-mandated processes.
More Articles on Orthopedic Devices:
8 New Orthopedic & Spine Device Launches
Mazor Robotics Finalizes Financing Agreement for Up To $15M
Spinal Elements to Launch Hero Allograft
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.